ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Addex Therapeutics Ltd

Addex Therapeutics Ltd (0QNV)

3.02
0.00
(0.00%)
Cerrado 01 Febrero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
3.02
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
3.02 Rango de 52 semanas 3.02
Capitalización de Mercado [m]
Precio Anterior
3.02
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
605
Acciones en circulación
184,354,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-52.71
Beneficio por acción (BPA)
-0.06
turnover
1.61M
Beneficio neto
-10.56M

Acerca de Addex Therapeutics Ltd

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Geneva, Che
Fundado
-
Addex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QNV. The last closing price for Addex Therapeutics was CHF3.02. Over the last year, Addex Therapeutics shares have traded in a share price range of CHF 3.02 to CHF 3.02.

Addex Therapeutics currently has 184,354,000 shares in issue. The market capitalisation of Addex Therapeutics is CHF556.75 million. Addex Therapeutics has a price to earnings ratio (PE ratio) of -52.71.

0QNV Últimas noticias

Addex to Present at the 2025 Swiss Equities Baader Conference

Addex to Present at the 2025 Swiss Equities Baader Conference Geneva, Switzerland, January 8, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on...

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update Indivior selected GABA B PAM drug candidate for development in substance use disorders (SUD) and starts IND...

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 Nine-month Results Remain On Track for Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva...

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update Launched Neurosterix with Perceptive Advisors to accelerate the development of M4PAM...

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024 - Addex...

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Geneva, Switzerland, September 4, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage...

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 27, 2024...

Addex’s Partner Discontinues ADX71149 development in Epilepsy

Addex’s Partner Discontinues ADX71149 development in Epilepsy Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a...

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland...

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1003.023.023.0200DE
4003.023.023.0253.02DE
12003.023.023.026053.02DE
26003.023.023.027413.02DE
52003.023.023.029223.02DE
156003.023.023.027913.02DE
260003.023.023.027613.02DE

0QNV - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Addex Therapeutics?
El precio actual de las acciones de Addex Therapeutics es CHF 3.02
¿Cuántas acciones de Addex Therapeutics están en circulación?
Addex Therapeutics tiene 184,354,000 acciones en circulación
¿Cuál es la capitalización de mercado de Addex Therapeutics?
La capitalización de mercado de Addex Therapeutics es CHF 556.75M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Addex Therapeutics?
Addex Therapeutics ha negociado en un rango de CHF 3.02 a CHF 3.02 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Addex Therapeutics?
El ratio precio/beneficio de Addex Therapeutics es -52.71
¿Cuál es el ratio de efectivo a ventas de Addex Therapeutics?
El ratio de efectivo a ventas de Addex Therapeutics es 347.13
¿Cuál es la moneda de reporte de Addex Therapeutics?
Addex Therapeutics presenta sus resultados financieros en CHF
¿Cuál es el último ingresos anual de Addex Therapeutics?
El último ingresos anual de Addex Therapeutics es CHF 1.61M
¿Cuál es el último beneficio anual de Addex Therapeutics?
El último beneficio anual de Addex Therapeutics es CHF -10.56M
¿Cuál es la dirección registrada de Addex Therapeutics?
La dirección registrada de Addex Therapeutics es 12 CHEMIN DES AULX, GENEVA, 1228
¿Cuál es la dirección del sitio web de Addex Therapeutics?
La dirección del sitio web de Addex Therapeutics es www.addextherapeutics.com
¿En qué sector industrial opera Addex Therapeutics?
Addex Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AIQAiq Limited
4.00p
(33.33%)
37.88k
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
ALKAlkemy Capital Investments Plc
175.00p
(27.27%)
176.27k
KNBKanabo Group Plc
1.00p
(25.00%)
461.04k
TCFTheracryf Plc
1.125p
(25.00%)
6.72M
MET1Metals One Plc
0.275p
(-35.29%)
16.2M
PPSProton Motor Power Systems Plc
0.175p
(-22.22%)
848.7k
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M
CGNRConroy Gold & Natural Resources Plc
2.15p
(-18.87%)
739.53k
ONCOncimmune Holdings Plc
10.40p
(-16.47%)
1.19M
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
NTVONativo Resources Plc
0.0018p
(-5.26%)
1.41B
MSMNMosman Oil And Gas Limited
0.041p
(10.81%)
1.22B
TRPTower Resources Plc
0.0295p
(0.00%)
691.76M
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M
Golden Cross Golden Cross 4 minutos hace
$GRLF .0001/.0002 The groundwork was laid in 2024. 2025 will be the
breakout year from this level with 500-1,500+% gains possible!
First Targets are .0005-.001 and very possible from here!

https://investorshub.advfn.com/uimage/uploads/2025/1/30/fwtnrfire-g.gif
GRLF
Countmein Countmein 4 minutos hace
I've only been following The Freedom Report for the last couple years, and Rob has always been calm, cool and collective in his reporting. In this video he goes completely off the rails than what I'm used to seeing from him! Maybe I just haven't watched him enough...........I don't know.
This
SLV
Kam8 Kam8 4 minutos hace
77


NWBO
B402 B402 5 minutos hace
Executive orders that are unconstitutional are a crime?? Any precedence for that....... or going to set a new one?

Seems like the courts will and are striking down anything against the constitution....
brooktrail1933 brooktrail1933 5 minutos hace
He dropped out first year, by his own admission.
The "Flaskworks is dead" prophet.
But he has an inside source he says. ............................
NWBO
Golden Cross Golden Cross 6 minutos hace
$GRLF .0001/.0002 The groundwork was laid in 2024. 2025 will be the
breakout year from this level with 500-1,500+% gains possible!
First Targets are .0005-.001 and very possible from here!

https://investorshub.advfn.com/uimage/uploads/2025/1/30/fwtnrfire-g.gif
GRLF
janice shell janice shell 7 minutos hace
Once again, I can only suggest you do some serious reading, not just regurgitate Trump's protectionist bullshit.

Does this sound good to you?

During the 1928 U.S. presidential campaign, Herbert Hoover vowed to raise prices on agricultural imports. However, as soon he to
B402 B402 9 minutos hace
Not only have they worked in the past and helped make us an industrial powerhouse, they are also a good negotiating tool.....

The countries we gave to now have leverage on us,,,,,,but at the same time, they are addicted to the billions in money stream we gave them, we have that on the
janice shell janice shell 11 minutos hace
Several of his ridiculous executive orders have been declared unconstitutional by federal judges. That really ought to be enough. After all, what they got Nixon on was his knowledge and approval of a "third rate burglary", not the much worse things he did.
Top Penny Top Penny 11 minutos hace
I want 250 million
PSRU
DarthYoda DarthYoda 12 minutos hace
"The FBI says crypto fraud cost Americans $5.6 billion a year. Here’s how you can stay safe":
The FBI says that while crypto fraud complaints only make up about 10% of financial fraud reports, they comprise 50% of total losses—about $5.6 billion in 2023 alone, according to the agency’s annual
XRPUSD
Tr8dervic Tr8dervic 12 minutos hace
Clash: 9, 11, 17, 22

THX !
123tom 123tom 13 minutos hace
I think it's possible to see , and forsee the track patterns of price movements pretty well. Using TA and a combination of tools and methods.... it becomes an exercise like looking at a road map. I liken it to a bus route, moving from station to station. as well as a rollercoaster, way up and way do
AVXL
B402 B402 14 minutos hace
Impeachment, find charges,,,,,,,,,,dems........best to start learning from all this, not repeat your past mistakes and priorities........
CrashOverride CrashOverride 14 minutos hace
All trading at MM is algorithmic.
NWBO
janice shell janice shell 15 minutos hace
Understanding the Smoot-Hawley Tariff Act

In June 1930, the Smoot-Hawley Tariff Act increased U.S. tariffs on agricultural imports and more than 20,000 imported goods. The tariffs imposed were the second-highest in American history. The goal was to protect American farmers who were mo
janice shell janice shell 19 minutos hace
Yes, they are tasty. Though for pure taste, I think I like poblanos better. Vast improvement on regular green peppers, sometimes with just a little heat.
B402 B402 20 minutos hace
Ah they have worked well, lol

Dems can't even admit to the 2 economies much rather trust them ;)

https://en.m.wikipedia.org/wiki/Tariff
Bigfootbud Bigfootbud 21 minutos hace
I created a fun thing back in 2020... OFFICIAL PET TRUMP - Remember THE PET ROCK??? YES it's mine... ♥ http://officialpettrump.com/
RickNagra RickNagra 21 minutos hace
Oh wow.  I am expecting exiting yugely yuge news Monday as per my algorithm.  I am a genius.  I am smarter than Einstein and Trump combined.  Newton was a fool compared to my vast knowledge and understanding of the universe and world and the physics of black holes and negative anti matter.  So get r
BMXI
Zorax Zorax 22 minutos hace
jalapeños are tasty and I guess that's why they're in so many recipes. Not always for the heat.
janice shell janice shell 22 minutos hace
Yes, you may be right about that. Probably even he doesn't think he'll live much longer.
JimmyTwoTimes JimmyTwoTimes 23 minutos hace
In the case of bioplastics, hemp could see some interesting opportunities if U.S. tariffs on traditional plastic imports—especially from countries like China—remain in place or escalate. Hemp-based bioplastics are a promising alternative to petroleum-based plastics, and with the increasing push for
OWPC
bas2020 bas2020 23 minutos hace
If it's 40M shares... the real question is how many times were those 40M shares traded with the manipulators' HFT churning algos?
NWBO

Su Consulta Reciente

Delayed Upgrade Clock